| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |